IL258185B - Oleanolic acid derivatives are modified at carbon 4 for il–17 inhibition and other uses - Google Patents

Oleanolic acid derivatives are modified at carbon 4 for il–17 inhibition and other uses

Info

Publication number
IL258185B
IL258185B IL258185A IL25818518A IL258185B IL 258185 B IL258185 B IL 258185B IL 258185 A IL258185 A IL 258185A IL 25818518 A IL25818518 A IL 25818518A IL 258185 B IL258185 B IL 258185B
Authority
IL
Israel
Prior art keywords
inhibition
acid derivatives
oleanolic acid
modified
modified oleanolic
Prior art date
Application number
IL258185A
Other languages
English (en)
Hebrew (he)
Other versions
IL258185A (en
Inventor
Melean Visnick
Xin Jiang
Martha R Hotema
Chitase Lee
Bradley William Caprathe
William H Roark
Gary Bolton
Original Assignee
Reata Pharmaceuticals Inc
Melean Visnick
Xin Jiang
Martha R Hotema
Chitase Lee
Bradley William Caprathe
William H Roark
Gary Bolton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reata Pharmaceuticals Inc, Melean Visnick, Xin Jiang, Martha R Hotema, Chitase Lee, Bradley William Caprathe, William H Roark, Gary Bolton filed Critical Reata Pharmaceuticals Inc
Publication of IL258185A publication Critical patent/IL258185A/en
Publication of IL258185B publication Critical patent/IL258185B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
IL258185A 2015-09-23 2018-03-18 Oleanolic acid derivatives are modified at carbon 4 for il–17 inhibition and other uses IL258185B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562222632P 2015-09-23 2015-09-23
PCT/US2016/053545 WO2017053868A1 (en) 2015-09-23 2016-09-23 C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses

Publications (2)

Publication Number Publication Date
IL258185A IL258185A (en) 2018-05-31
IL258185B true IL258185B (en) 2021-08-31

Family

ID=57137257

Family Applications (1)

Application Number Title Priority Date Filing Date
IL258185A IL258185B (en) 2015-09-23 2018-03-18 Oleanolic acid derivatives are modified at carbon 4 for il–17 inhibition and other uses

Country Status (14)

Country Link
US (2) US11584775B2 (cg-RX-API-DMAC7.html)
EP (1) EP3353190B1 (cg-RX-API-DMAC7.html)
JP (1) JP7074674B2 (cg-RX-API-DMAC7.html)
KR (1) KR102796889B1 (cg-RX-API-DMAC7.html)
CN (1) CN108290922B (cg-RX-API-DMAC7.html)
AU (1) AU2016326704B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018005861B1 (cg-RX-API-DMAC7.html)
CA (1) CA2998681C (cg-RX-API-DMAC7.html)
EA (1) EA201890767A1 (cg-RX-API-DMAC7.html)
ES (1) ES2865163T3 (cg-RX-API-DMAC7.html)
IL (1) IL258185B (cg-RX-API-DMAC7.html)
MX (1) MX386256B (cg-RX-API-DMAC7.html)
NZ (1) NZ741082A (cg-RX-API-DMAC7.html)
WO (1) WO2017053868A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009129546A1 (en) 2008-04-18 2009-10-22 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
MX357060B (es) 2012-04-27 2018-06-25 Reata Pharmaceuticals Inc Derivados de 2,2-difluoropropionamida de bardoxolon metilo, formas polimorficas y metodo para su uso de los mismos.
US9512094B2 (en) 2012-09-10 2016-12-06 Reata Pharmaceuticals, Inc. C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
UY35023A (es) 2012-09-10 2014-03-31 Reata Pharmaceuticals Inc Derivados c17-alcandiilo y alquendiilo del ácido oleanólico y sus métodos de uso
UY39092A (es) 2013-04-24 2021-03-26 Abbvie Inc Derivados de 2,2-difluoropropanamida y metil bardoxolona, formas polimórficas y métodos de uso
BR112019009256A2 (pt) 2016-11-08 2019-07-16 Reata Pharmaceuticals Inc métodos para tratar síndrome de alport usando bardoxolona metil ou análogos do mesmo
CN108191944B (zh) * 2018-01-18 2020-12-11 华南师范大学 海洋微生物来源的二倍半萜AsperterpinolB衍生物及合成方法与糖酶应用
CN108299541B (zh) * 2018-01-18 2020-12-11 华南师范大学 海洋微生物来源的二倍半萜AsperterpinolB衍生物及合成方法与抗炎应用
US12060340B2 (en) 2018-06-20 2024-08-13 Reata Pharmaceuticals, Inc Cysteine-dependent inverse agonists of nuclear receptors ROR-gamma/ROR-gamma-t and methods of treating diseases or disorders therewith
CN109248168A (zh) * 2018-10-30 2019-01-22 武汉卫无忧生物科技有限公司 齐墩果酸在制备抗幽门螺杆菌的药物中的用途
TWI752400B (zh) 2019-01-07 2022-01-11 美商美國禮來大藥廠 Il-17a抑制劑
CN114641483B (zh) * 2019-07-19 2024-12-06 里亚塔医药公司 C17极性的-取代的杂芳族合成三萜类化合物及其使用方法
WO2022126129A1 (en) 2020-12-11 2022-06-16 Reata Pharmaceuticals, Inc. Synthetic triterpenoids for use in therapy
AU2022208727A1 (en) * 2021-01-18 2023-08-03 Reata Pharmaceuticals, Inc. Synthetic ursolic acid derivatives and methods of use thereof
CN113185570A (zh) * 2021-05-12 2021-07-30 张洪胜 一种治疗银屑病的齐墩果酸衍生物及其制备方法
CN117964678A (zh) * 2024-01-29 2024-05-03 烟台大学 C17位杂芳族羰基修饰的齐墩果烷三萜衍生物及其制备方法和用途

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4395423A (en) 1978-10-10 1983-07-26 Sterling Drug Inc. Polycyclic cyanoketones
US5064823A (en) 1988-08-24 1991-11-12 Research Triangle Institute Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
DE19817262A1 (de) 1998-04-18 1999-10-21 Bayer Ag Neue 2-heterocyclisch substituierte Dihydropyrimidine
US6326507B1 (en) 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
US6369101B1 (en) 1999-02-26 2002-04-09 Regents Of The University Of Minnesota Therapeutic method to treat herpes virus infection
ATE370928T1 (de) 1999-05-14 2007-09-15 Nereus Pharmaceuticals Inc Interleukin-1 und tumornekrosefaktor-alpha modulatoren,synthese dieser modulatoren und methoden zur anwendung dieser modulatoren
US6649654B1 (en) 1999-11-23 2003-11-18 The Regents Of The University Of California Methods for identifying and using IKK inhibitors
WO2002003996A1 (en) 2000-07-12 2002-01-17 RAJKUMAR, Sujatha Use of dammarane-type tritepenoid saporins
EP1322661A1 (en) 2000-09-29 2003-07-02 Regents Of The University Of Minnesota Triterpenes having fungicidal activity against yeast
US6951847B2 (en) 2000-09-29 2005-10-04 Regents Of The University Of Minnesota Methods of treating fungal infections using lupeol
WO2002026762A1 (en) 2000-09-29 2002-04-04 Regents Of The University Of Minnesota Triterpenes having antibacterial activity
US6878751B1 (en) 2000-10-19 2005-04-12 Imperial College Of Science Technology And Medicine Administration of resveratrol to treat inflammatory respiratory disorders
US7435755B2 (en) 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
WO2002047611A2 (en) 2000-11-28 2002-06-20 Board Of Regents, The University Of Texas System Cddo-compounds and combination therapies thereof
AU2002308701A1 (en) 2001-05-14 2002-11-25 University Of Maryland, Baltimore Novel alanine transaminase enzyme and methods of use
EP1465615B1 (en) 2002-01-15 2012-08-01 Trustees of Dartmouth College Tricyclic-bis-enone derivatives and methods of use thereof
MXPA04006953A (es) 2002-01-18 2005-06-20 Univ Minnesota Sales cuaternarias de triperpeno como surfactantes biologicamente activos.
CA2485565A1 (en) 2002-05-13 2004-08-05 Trustees Of Dartmouth College Inhibitors and methods of use thereof
WO2004089357A2 (en) 2003-04-02 2004-10-21 Regents Of The University Of Minnesota Anti-fungal formulation of triterpene and essential oil
US20050208151A1 (en) 2003-10-30 2005-09-22 Entelos, Inc. Treatment of rheumatoid arthritis with FLIP antagonists
US8288439B2 (en) 2003-11-04 2012-10-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and compositions for the inhibition of HIV-1 replication
US20060258752A1 (en) 2004-02-12 2006-11-16 Vander Jagt David L Method and compounds for cancer treatment utilizing NFkB as a direct or ultimate target for small molecule inhibitors
JP2005314381A (ja) 2004-03-30 2005-11-10 Anges Mg Inc 増殖性腎疾患の予防・治療・改善剤
JP5087400B2 (ja) 2004-09-07 2012-12-05 パシフィック アロー リミテッド アンゲロイル基を有する抗腫瘍化合物
WO2007005879A2 (en) 2005-07-01 2007-01-11 The Johns Hopkins University Compositions and methods for the treatment or prevention of disorders relating to oxidative stress
JP2009530405A (ja) 2006-03-23 2009-08-27 アドバンスト ライフ サイエンシズ インコーポレイテッド 合成五環性トリテルペノイド、ならびにベツリン酸およびベツリンの誘導体
WO2007127791A2 (en) 2006-04-25 2007-11-08 The Administrators Of The Tulane Educational Fund New pharmacological method for treatment of neuropathic pain
WO2008000070A1 (en) 2006-06-27 2008-01-03 Wellington Laboratories Inc. Glycyrrhetinic acid derivatives
WO2008016095A1 (en) 2006-08-02 2008-02-07 Santen Pharmaceutical Co., Ltd. PREVENTIVE OR REMEDY FOR KERATOCONJUNCTIVAL DISORDERS CONTAINING Nrf2 ACTIVATOR AS THE ACTIVE INGREDIENT
WO2008064132A2 (en) 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
JP2010510243A (ja) 2006-11-17 2010-04-02 トラスティーズ オブ ダートマス カレッジ 三環系−ビス−エノン（ｔｂｅ）の合成および生物学的活性
DK2629097T1 (da) 2007-02-08 2022-05-30 Biogen Ma Inc NRF2-screeningsassays og relaterede fremgangsmåder og sammensætninger
JP2008247898A (ja) 2007-03-08 2008-10-16 Santen Pharmaceut Co Ltd トリテルペノイドを有効成分として含有する酸化ストレスが関連する眼疾患の予防又は治療剤
WO2008136838A1 (en) 2007-05-04 2008-11-13 Trustees Of Dartmouth College Novel amide derivatives of cddo and methods of use thereof
US8088824B2 (en) 2007-08-15 2012-01-03 Reata Pharmaceuticals Inc. Forms of CDDO methyl ester
WO2009023845A2 (en) 2007-08-15 2009-02-19 The Board Of Regents Of The University Of Texas System Combination therapy with synthetic triterpenoids and gemcitabine
US9012439B2 (en) 2007-10-29 2015-04-21 University Of Rochester Use of electrophilic compounds for inducing platelet production or maintaining platelet function
EP3492077A1 (en) 2008-01-11 2019-06-05 Reata Pharmaceuticals, Inc. Synthetic triterpenoids and methods of use in the treatment of disease
KR101782020B1 (ko) 2008-04-18 2017-09-26 리타 파마슈티컬스 잉크. 산화방지성 염증 조절제 ｃ-17 일치된 올레아놀산 유도체
WO2009129546A1 (en) 2008-04-18 2009-10-22 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
AU2009251437B2 (en) 2008-04-18 2014-10-30 Reata Pharmaceuticals, Inc. Compounds including an anti-inflammatory pharmacore and methods of use
TW201004627A (en) 2008-04-18 2010-02-01 Reata Pharmaceuticals Inc Antioxidant inflammation modulators: novel derivatives of oleanolic acid
AU2009237578C1 (en) 2008-04-18 2014-12-04 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring
CN101298466B (zh) 2008-06-13 2014-04-09 南京大学 齐墩果酸衍生物及其制备方法和应用
ES2449396T3 (es) 2008-07-22 2014-03-19 Trustees Of Dartmouth College Cianoenonas monocíclicas y métodos de uso de las mismas
WO2010053817A1 (en) 2008-11-04 2010-05-14 Trustees Of Dartmouth College Betulinic acid derivatives and methods of use thereof
HUE035013T2 (en) 2009-02-13 2018-05-02 Reata Pharmaceuticals Inc Delayed release, oral dosage compositions that contain amorphous cddo-me
ME03713B (me) 2010-04-12 2021-01-20 Reata Pharmaceuticals Inc Bardoksolon meтil za lečenje gojaznosтi
US8618125B2 (en) * 2011-01-14 2013-12-31 Heptiva LLC Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance
EP2670765B1 (en) 2011-01-31 2017-10-18 Viiv Healthcare Uk (No. 4) Limited C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity
BR112013023174B1 (pt) * 2011-03-11 2021-09-21 Reata Pharmaceuticals, Inc Compostos derivados de triterpenoide de c4-monometila e composição farmacêutica compreendendo os referidos compostos
WO2013079024A1 (zh) 2011-12-01 2013-06-06 杭州本生药业有限公司 齐墩果酸酰胺化衍生物、及其制备方法和应用
MX357060B (es) 2012-04-27 2018-06-25 Reata Pharmaceuticals Inc Derivados de 2,2-difluoropropionamida de bardoxolon metilo, formas polimorficas y metodo para su uso de los mismos.
WO2013169740A2 (en) 2012-05-08 2013-11-14 Trustees Of Dartmouth College Synthetic triterpenoids and methods for modulating stem/progenitor cell gene expression
US8921419B2 (en) 2012-05-08 2014-12-30 Trustees Of Dartmouth College Triterpenoids and compositions containing the same
WO2013188818A1 (en) * 2012-06-15 2013-12-19 Reata Pharmaceuticals, Inc. A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
CN103665087A (zh) 2012-09-03 2014-03-26 上海源力生物技术有限公司 一种萜类化合物及其在医药上的应用
WO2014040073A1 (en) 2012-09-10 2014-03-13 Reata Pharmaceuticals, Inc. C13-hydroxy derivatives of oleanolic acid and methods of use thereof
US9512094B2 (en) 2012-09-10 2016-12-06 Reata Pharmaceuticals, Inc. C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
WO2014040056A1 (en) 2012-09-10 2014-03-13 Reata Pharmaceuticals, Inc. C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
UY35023A (es) 2012-09-10 2014-03-31 Reata Pharmaceuticals Inc Derivados c17-alcandiilo y alquendiilo del ácido oleanólico y sus métodos de uso
IL285832B2 (en) 2013-08-23 2024-01-01 Reata Pharmaceuticals Inc Methods for the treatment and prevention of impaired functioning of the endothelium using brodoxolone methyl or its analogs
CN104861027A (zh) 2014-02-24 2015-08-26 上海兰蒂斯生物医药科技有限公司 新型齐墩果酸衍生物、其制备方法及其应用
WO2016033132A1 (en) 2014-08-26 2016-03-03 Trustees Of Dartmouth College Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole
BR112019009256A2 (pt) 2016-11-08 2019-07-16 Reata Pharmaceuticals Inc métodos para tratar síndrome de alport usando bardoxolona metil ou análogos do mesmo

Also Published As

Publication number Publication date
KR20180061251A (ko) 2018-06-07
AU2016326704A1 (en) 2018-04-26
MX2018003569A (es) 2018-11-29
EA201890767A1 (ru) 2019-09-30
BR112018005861A2 (pt) 2018-10-16
CN108290922B (zh) 2021-12-07
ES2865163T3 (es) 2021-10-15
IL258185A (en) 2018-05-31
EP3353190A1 (en) 2018-08-01
EP3353190B1 (en) 2021-03-17
KR102796889B1 (ko) 2025-04-17
CA2998681A1 (en) 2017-03-30
CA2998681C (en) 2024-02-06
WO2017053868A1 (en) 2017-03-30
US20230250130A1 (en) 2023-08-10
JP2018528275A (ja) 2018-09-27
WO2017053868A8 (en) 2018-04-19
AU2016326704B2 (en) 2021-01-28
US20190153022A1 (en) 2019-05-23
JP7074674B2 (ja) 2022-05-24
HK1258095A1 (zh) 2019-11-01
NZ741082A (en) 2023-06-30
CN108290922A (zh) 2018-07-17
MX386256B (es) 2025-03-18
BR112018005861B1 (pt) 2022-11-22
US11584775B2 (en) 2023-02-21

Similar Documents

Publication Publication Date Title
IL258185B (en) Oleanolic acid derivatives are modified at carbon 4 for il–17 inhibition and other uses
IL285553A (en) Use of prg4 as an anti-inflammatory agent
ZA201707981B (en) Compositions of obeticholic acid and methods of use
IL257235A (en) Methods for preparation of bile acids and derivatives thereof
EP3331530A4 (en) Mthfd2 inhibitors and uses thereof
SG11201706917WA (en) Salts of pi3k inhibitor and processes for their preparation
IL259796A (en) Aza-benzimidazole inhibitors of pad4
IL258922A (en) Methods for the preparation of obeticholic acid and derivatives thereof
PL3313833T3 (pl) Związki i ich zastosowanie w charakterze inhibitorów transferazy n-mirystoilu
IL256971A (en) Methods for preparation of bile acids and derivatives thereof
IL247529B (en) Preparations of choline ester lipoic acid and methods of use
GB201521059D0 (en) Inhibitors of metallo-beta-lactamases
EP3177327A4 (en) Inhibitors of myh7b and uses thereof
GB201522764D0 (en) Formulations of phosphate derivatives
EP3193939A4 (en) Small lipopeptidomimetic inhibitors of ghrelin o-acyl transferase
GB2561121B (en) Branched acid emulsifier compositions and methods of use
SG10202008700VA (en) α-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF
IL262405A (en) Methods for preparing obeticholic acid and its derivatives
IL249463A0 (en) Production method for (s)-2-acetyloxypropionic acid and their derivatives
EP3225237A4 (en) Fatty acid amides for the prevention and/or treatment of steatohepatitis
PL3143032T3 (pl) Nowe pochodne oksazafosforyn i ich zastosowania terapeutyczne
ZA201707777B (en) Pharmaceutical formulation for the treatment of inflammatory changes to the rectum
EP3267795A4 (en) Synthesis of cyclocreatine and analogs thereof
AU2015903172A0 (en) Inhibitors of necroptosis
GB201511863D0 (en) Pharmaceutical compositions comprising hexaminolevulnic acid and methods of using the same